icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Re-assessment of the Actual Benefit
Clinical Benefit
Insufficient
The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia".
Therapeutic use
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
M83MWM5tctYkb1d2